Mark R. Benedict is a partner for Knobbe Martens, one of the largest and fastest-growing IP law firms. He specializes in patent prosecution and strategic intellectual property portfolio management for pharmaceutical, biotechnology and life science clients.
Dr. Benedict’s practice includes patent prosecution, counseling on patent infringement, validity and licensing issues, management of patent and other intellectual property assets, intellectual property due diligence studies and related counseling for investors. He currently represents clients in a wide range of technology areas, including pharmaceuticals, biotechnology, engineered industrial enzymes, cellulosic ethanol production, animal and fish feed supplements, pigment extraction from plant materials, cosmetic chemistry, medical devices and other life sciences. He also represents a number of foreign associates in procuring U.S. patent protection for their clients in the pharmaceutical and biotechnology areas.
Prior to joining Knobbe Martens, Dr. Benedict worked as a Research Assistant Professor of Pediatrics at the State University of New York, Upstate Medical Center, where he conducted basic and clinical research, under grants from the NIH and the American Heart Association, on the molecular and biochemical mechanisms of hormone and growth factor regulation of vascular smooth muscle cell proliferation, differentiation and aging. Prior to joining the faculty, he worked at the SUNY medical school as a post-doctoral research fellow in Pediatric Endocrinology. During his tenure at SUNY, Dr. Benedict published and spoke extensively in the areas of endocrinology and aging.
Dr. Benedict joined the Knobbe Martens in 1997 and became a partner in 2003.